DHA awards $670.6M TRICARE pharmacy option
DHA awarded Express Scripts Inc., of St. Louis, a $670.6 million contract modification for the third option period of its TRICARE Pharmacy Benefit Program. The award (P00059, HT940221C0007) ensures pharmacy benefit services remain accessible across the United States, Washington, DC, and US territories through retail and mail-order pharmacies. The option period spans calendar 2025 and is incrementally funded with fiscal 2025 O&M funds. DHA's Managed Care Contracting Division in Aurora, Colorado, oversees the contract.
Comments ()